FRIDAY, Feb. 21, 2025 — Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.
The study followed 16 patients…
You may also like
Boston Scientific Recalls Accolade Pacemaker Devices
Listeria Outbreak From Frozen Shakes Kills 12, Sickens...
Most Americans Don’t Know These Heart Disease Risks...
Study Finds No Spike in Cardiac Arrest in Athletes...
Breast Cancer A Killer In Poor Countries, Report Says
More ER Docs Prescribing Meds To Fight Opioid Addiction
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.